BVX — Bivictrix Therapeutics Share News
0.000.00%
Last trade - 00:00BiVictriX Therapcts. - Positive In Vivo Data from BVX002 Programme
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Director Dealing
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - TR-1: Notification of major holdings
BiVictriX Therapcts. - Grant of Options
BiVictriX Therapcts. - Interim Results
BiVictriX Therapcts. - Publication of 2023 Annual Report & Notice of AGM
BiVictriX Therapcts. - BiVictriX – Full Year Results 2023
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Holding(s) in Company
BiVictriX Therapcts. - Board Change
BiVictriX Therapcts. - Pipeline update on BVX002
BiVictriX Therapcts. - Holding(s) in Company
Brief: Bivictrix Therapeutics Says Patent Granted In Japan Providing Further Broad Protection For BVX001
Brief: Bivictrix Therapeutics PLC Extended Survival Rates Reported With Bvx001 In A Pre-Clinical Model Of Acute Myeloid Leukaemia
Brief: BiVictriX Therapeutics Announces Appointment Of Adrian Howd As CFO
Brief: BiVictriX Therapeutics Says Cash And Cash Equivalents Of £1.9 Mln At June 30